Avidity Biosciences RNA Therapeutics Investor Presentation 2023

Avidity Biosciences presents its RNA therapeutic platform and clinical development programs, including pipeline candidates AOC 1001, AOC 1020, and AOC 1044 targeting muscular dystrophies and other genetic diseases. The company outlines its vision to revolutionize RNA therapeutic delivery through its proprietary AOC platform technology.